Skin Reactions to Cancer Immunotherapy Request More Information Trial Objective A new cancer treatment, called immunotherapy, enhances the body’s immune response to attack and kill cancers. However, by changing the body’s immune response, unwanted side effects can occur. This study focuses on side effects caused by immunotherapy, specifically skin reactions. The purpose of this study is to understand what changes in the immune system, and how these changes lead to skin reactions as a side effect. By understanding these changes, our goal is to define the best treatment for the skin reactions, or possibly prevent the reactions. Enrollment Active Clinical Trials Currently Recruiting Who Can Participate Adults who have been diagnosed with a solid tumor who are starting or already receiving immunotherapy for cancer treatment. Age: 18+ Gender: Any Gender Estimated Time Commitment Up to 2 visits over 3 months, with possible phone follow-up after 12 months depending on cancer treatment response × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Daniell Plomondon 303.270.2041 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors National Institute of Arthritis and Musculoskeletal and Skin Diseases Principal Investigators Donald Leung, PhD, MD + × Donald Leung, PhD, MD Distinguished Professor Head, Division of Pediatric Allergy & Immunology Department of Pediatrics Edelstein Family Chair in Pediatric Allergy and Clinical Immunology View Full Profile Make an Appoinment Jeffrey Kern, MD + × Jeffrey Kern, MD Chief, Division of Oncology, Cancer Center Director, Lung Cancer Center Vice Chair, Finance Professor Department of Medicine View Full Profile Make an Appoinment Request More Information By completing this form, you agree to learn more about this study and see if you qualify. First Name:* Last Name:* Email Address:* Phone:* I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: YesNo
Trial Objective A new cancer treatment, called immunotherapy, enhances the body’s immune response to attack and kill cancers. However, by changing the body’s immune response, unwanted side effects can occur. This study focuses on side effects caused by immunotherapy, specifically skin reactions. The purpose of this study is to understand what changes in the immune system, and how these changes lead to skin reactions as a side effect. By understanding these changes, our goal is to define the best treatment for the skin reactions, or possibly prevent the reactions.